TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

AstraZeneca's Big Bet on Oncology May Finally Pay Off
HEALTH

AstraZeneca drops partnership with Regulus after ditching drug

  • By Melissa Angell
  • Jun 13, 2017 1:12 PM EDT
PRESS RELEASES

Regulus Therapeutics Announces Closing Of $19.4 Million Private Placement Of Equity

  • By PR Newswire
  • Dec 8, 2020 8:07 AM EST
PRESS RELEASES

Regulus Therapeutics Collaborates With Bio-Techne For Biomarker Development

  • By PR Newswire
  • Dec 2, 2020 7:00 AM EST
PRESS RELEASES

Regulus Therapeutics Announces Private Placement Of Equity

  • By PR Newswire
  • Dec 1, 2020 8:35 AM EST
PRESS RELEASES

Regulus Therapeutics Announces Achievement Of Interim Enrollment Milestone Under Collaboration With Sanofi

  • By PR Newswire
  • Nov 2, 2020 8:07 AM EST
PRESS RELEASES

Regulus Therapeutics Announces First Patient Dosed In Phase 1b Clinical Trial Of RGLS4326 For The Treatment Of Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  • By PR Newswire
  • Oct 15, 2020 8:07 AM EDT
PRESS RELEASES

Regulus Therapeutics Announces Receipt Of $5 Million Milestone And Material Payments From Sanofi

  • By PR Newswire
  • Oct 13, 2020 8:07 AM EDT
PRESS RELEASES

Regulus Therapeutics To Present At The 2020 Wells Fargo Virtual Healthcare Conference

  • By PR Newswire
  • Sep 3, 2020 8:07 AM EDT
PRESS RELEASES

Regulus Therapeutics Announces Restructuring Of Sanofi And Oxford Loan Agreements

  • By PR Newswire
  • Aug 31, 2020 8:07 AM EDT
PRESS RELEASES

Regulus Therapeutics To Present At The 2020 Wedbush PacGrow Healthcare Virtual Conference

  • By PR Newswire
  • Aug 6, 2020 8:07 AM EDT
PRESS RELEASES

Regulus Therapeutics Appoints Denis Drygin, Ph.D., As Chief Scientific Officer

  • By PR Newswire
  • Aug 3, 2020 8:07 AM EDT
PRESS RELEASES

Regulus Therapeutics Announces FDA Orphan Drug Designation Of RGLS4326 For The Treatment Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  • By PR Newswire
  • Jul 29, 2020 8:07 AM EDT
PRESS RELEASES

Regulus Therapeutics Completes Dosing In Phase 1 Multiple Ascending Dose Study Of RGLS4326 In Healthy Volunteers For The Treatment Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  • By PR Newswire
  • Jul 22, 2020 8:07 AM EDT
PRESS RELEASES

Regulus Therapeutics Reinitiates Multiple Ascending Dose Study Of RGLS4326 For The Treatment Of ADPKD

  • By PR Newswire
  • Feb 13, 2020 4:30 PM EST
PRESS RELEASES

Regulus Therapeutics Announces FDA Removal Of Partial Clinical Hold For Multiple Ascending Dose Study Of RGLS4326

  • By PR Newswire
  • Dec 16, 2019 8:00 AM EST
AstraZeneca's Big Bet on Oncology May Finally Pay Off
HEALTH

AstraZeneca drops partnership with Regulus after ditching drug

  • By Melissa Angell
  • Jun 13, 2017 1:12 PM EDT
Trade-Ideas: Marvell Technology Group (MRVL) Is Today's Post-Market Leader Stock
MARKETS

Regulus Therapeutics (RGLS): Today's Weak On High Volume Stock

  • By TheStreet Wire
  • Jun 1, 2016 10:02 AM EDT
Energy Transfer Equity (ETE) Is Today's Dead Cat Bounce Stock
MARKETS

Regulus Therapeutics (RGLS): Today's Weak On High Volume Stock

  • By TheStreet Wire
  • Apr 27, 2016 10:04 AM EDT
Insider Trading Alert - DUK, STFC And RGLS Traded By Insiders
MARKETS

Regulus Therapeutics (RGLS) Is Strong On High Volume Today

  • By TheStreet Wire
  • Apr 21, 2016 10:01 AM EDT
Perilous Reversal Watch: Golar LNG (GLNG)
MARKETS

Regulus Therapeutics (RGLS) Is Weak On High Volume Today

  • By TheStreet Wire
  • Apr 18, 2016 10:09 AM EDT
Today's Weak On High Volume Stock: Primero Mining (PPP)
MARKETS

Insider Trading Alert - AIRM, RGLS And AAON Traded By Insiders

  • By TheStreet Wire
  • Mar 8, 2016 11:00 AM EST
Energy Transfer Equity (ETE) Is Today's Dead Cat Bounce Stock
MARKETS

Regulus Therapeutics (RGLS) Is Today's Dead Cat Bounce Stock

  • By TheStreet Wire
  • Feb 26, 2016 10:06 AM EST
Insider Trading Alert - DUK, STFC And RGLS Traded By Insiders
MARKETS

Insider Trading Alert - DUK, STFC And RGLS Traded By Insiders

  • By TheStreet Wire
  • Feb 25, 2016 11:45 AM EST
Stock Futures Lower With Dow's Record Streak Under Threat Again
OPINION

4 momentum stocks making strong moves to watch

  • By Harry Boxer
  • Feb 18, 2016 12:39 PM EST
Univar to Buy Nexeo for $2 Billion
MARKETS

Regulus (RGLS) Stock Soars on Interim Trial Results for Hepatitis C Virus Treatment

  • By Amanda Albright
  • Feb 17, 2016 11:12 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.